OMEPRAZOLE ALMUS 20 mg, gastro-resistant capsule 14 capsules, CIP 3400949763184
Active ingredients: Omeprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule14 capsules, CIP 3400949763184orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OMEPRAZOLE ALMUS 20 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 14 gélule(s)
- Marketing authorisation holder
- ALMUS FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Feb 2021
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60806188CIP74976318CIP133400949763184Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OMÉPRAZOLEgélule | 20 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 7 capsules, CIP 3400949763016Commercialized according to BDPM
- 28 capsules, CIP 3400949763245Commercialized according to BDPM
- 7 capsules, CIP 3400949763535Commercialized according to BDPM
- 14 capsules, CIP 3400949763764Commercialized according to BDPM
- 28 capsules, CIP 3400949763993Commercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.